Abstract

BackgroundRetrospective analysis and pre-clinical studies suggest that local anesthetics have anti-tumoral effects. However, the association between cancer recurrence and the use of local anesthesia is inconclusive and most reports are based on single local anesthetic results.MethodsThe biological effects (growth, migration and survival) of four common local anesthetics on esophageal carcinoma cells were compared. Biochemical assays on molecules involved in cell migration and proliferation were analyzed.ResultsRopivacaine and bupivacaine significantly inhibited esophageal carcinoma cell migration, at clinically relevant micromolar concentrations. Mepivacaine and lidocaine showed less potent cell migration inhibition than ropivacaine or bupivacaine. All four local anesthetics inhibited cell proliferation. Of note, the effective concentration of anti-proliferative activities requires higher doses. At millimolar concentrations of these local anesthetics, cell apoptosis was moderately affected. Drug combination analysis demonstrated that two of four local anesthetics augmented chemotherapeutic drugs in inhibiting migration. However, all four local anesthetics significantly augmented chemotherapeutic drugs in inhibiting growth and inducing apoptosis. The anti-growth and anti-survival effects of four local anesthetics were attributed to mitochondrial dysfunction and oxidative damage. The anti-migratory effect of local anesthetics is likely through decreasing Rac1 activity.ConclusionsOur work demonstrates the differential effects and proposes the mechanisms of local anesthetics on esophageal carcinoma cell migration, growth, survival and chemosensitivity.

Highlights

  • Retrospective analysis and pre-clinical studies suggest that local anesthetics have anti-tumoral effects

  • The differential effects of local anesthetics on esophageal carcinoma cell migration To establish the effects of local anesthetics on esophageal carcinoma metastasis, we conducted the Boyden Chamber migration assay using OE19 and SK-GT-4 cells in the presence of local anesthetics: mepivacaine, bupivacaine, lidocaine and ropivacaine

  • OE-19 was derived from an adenocarcinoma of a gastric/esophageal junction and SK-GT-4 was derived from a well-differentiated adenocarcinoma of the distal esophagus

Read more

Summary

Introduction

Retrospective analysis and pre-clinical studies suggest that local anesthetics have anti-tumoral effects. The association between cancer recurrence and the use of local anesthesia is inconclusive and most reports are based on single local anesthetic results. Despite advances in diagnostics and therapeutics, the five year survival rate in esophageal carcinoma remains poor [1]. Surgery remains the main curative option for advance local esophageal cancer to improve patient survival. Studies suggest that anesthetics used in the perioperative period can potentially influence cancer recurrence [3, 4]. Certain local anaesthesia reduce cancer recurrence in a number of retrospective studies. These studies have small sizes and are subjected to selection bias [4,5,6,7]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.